BNY · Bank of New York Mellon Corp
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Banks - Diversified — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BNY
this stock
Bank of New York Mellon Corp
|
$99.73B | +24.6% | +7.8% | 17.1 | 1.5% |
|
JPM
Jpmorgan Chase & Co
|
$911.92B | +2.7% | +2.8% | 14.7 | 0.0% |
|
BAC
Bank Of America Corp /De/
|
$384.32B | -1.0% | +6.8% | 12.7 | 1.2% |
|
HSBC
Hsbc Holdings PLC
|
$345.38B | +26.2% | — | — | 0.2% |
|
RY
Royal Bank Of Canada
|
$279.63B | +15.3% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BNY | -3.3% | -9.9% | +12.5% | -10.3% | +24.6% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -2.6% | -10.0% | +0.3% | -9.7% | +12.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.